GlassScriptPhysician profile
Jamie M Bisel
NPI 1255692232
$10,824.03
in general payments reported to CMS, 2019-2025
54 companies · $2,745 in 2025
The $2,745 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,709 · 2022: $1,645 · 2023: $2,385 · 2024: $2,340 · 2025: $2,745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,470.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,533.50 | 2021-2025 | |
| Novo Nordisk INC | $1,112.71 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $735.50 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $690.54 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Corium, LLC | $570.59 | 2022-2025 | Azstarys |
| Amgen INC. | $556.24 | 2022-2025 | Repatha, Otezla, Evenity |
| Pfizer INC. | $530.79 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $364.13 | 2023-2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $313.79 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $295.36 | 2022-2025 | |
| Sunovion Pharmaceuticals INC. | $263.30 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $254.74 | 2022-2025 | Rexulti, Nuedexta |
| Axsome Therapeutics, INC. | $249.03 | 2023-2025 | Auvelity, Sunosi |
| Glaxosmithkline, LLC. | $211.28 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $194.88 | 2021-2022 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Bisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.